Maynard Um
-
-
-
-
-
-
-
Stephens Starts Palvella Therapeutics (PVLA) at Overweight
-
-
-
-
-
-
-
Palvella publishes research on lymphatic malformation subtypes
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $210 at Truist Securities
-
-
-
-
-
-
-
Clear Street Reiterates Buy Rating on Palvella Therapeutics (PVLA)
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $193 at Raymond James
-
-
-
-
-
-
-
Palvella Therapeutics (PVLA) PT Raised to $204 at Canaccord Genuity
-
-
-
-
-
-
-
BTIG Starts Palvella Therapeutics (PVLA) at Buy
-
421,050 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

